PD
RLYB icon

Point72 (DIFC)’s Rallybio RLYB Stock Holding History

Point72 (DIFC)’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-122
Closed -$638 – 2018
2025
Q1 		$638 Sell
122
-619
-84% -$3.91K ﹤0.01% 1595
2024
Q4 		$5.69K Sell
741
-277
-27% -$2.32K ﹤0.01% 1380
2024
Q3 		$9.53K Sell
1,018
-724
-42% -$6.97K ﹤0.01% 1267
2024
Q2 		$18.7K Buy
+1,742
New +$23.6K ﹤0.01% 1250

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

Point72 (DIFC)'s RLYB Position: Q2 2025 in Review

Point72 (DIFC) sold out of Rallybio (RLYB) in Q2 2025, closing a stake of 122 shares — an estimated $638 sold.

Point72 (DIFC) first reported a position in RLYB in Q2 2024 and held it in 4 quarters. The position peaked at $18.7K in Q2 2024. 48 funds tracked by Wall St. Rank hold RLYB as of Q2 2025.

  • Point72 (DIFC) reported no remaining Rallybio position as of Q2 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 122 Rallybio shares in Q2 2025, an estimated $638.
  • Point72 (DIFC) first reported a position in Rallybio in Q2 2024 and held it in 4 quarters.
  • Point72 (DIFC)'s Rallybio position peaked at $18.7K in Q2 2024.
  • 48 funds tracked by Wall St. Rank held Rallybio as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.